CompletedNot Applicable

Early Pregnancy Serum Ferritin Levels as a Predictor for Gestational Diabetes Mellitus

Egypt556 participantsStarted 2022-12-05

Plain-language summary

This prospective study evaluates a target population of pregnant women at the time of pregnancy diagnosis to investigate the predictive value of serum ferritin (SF) levels for the later development of gestational diabetes mellitus (GDM). The intervention involves measuring early-pregnancy SF, transferrin, and hemoglobin levels, alongside HbA1c, and comparing these biomarkers between women who later develop GDM and those who remain normoglycemic. The primary outcome is to assess the success rate of this diagnostic regimen in identifying high-risk individuals, aiming to establish SF as a valuable early biomarker for GDM to enable timely interventions.

Who can participate

Age range21 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Confirmed pregnancy at an early gestational age. * Provision of clinical and family history (e.g., age, BMI, history of GDM). Exclusion Criteria: * Pre-existing Type 1 or Type 2 Diabetes Mellitus. * Conditions known to significantly alter iron metabolism independent of pregnancy.

What they're measuring

Success Rate of Diagnostic Regimens in Predicting Gestational Diabetes Mellitus

Timeframe: 24-28 weeks gestation

Trial details

NCT IDNCT07433465

SponsorZagazig University

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2024-12-07

View on ClinicalTrials.gov More Diabetes Mellitus trials